PD-1 is expressed primarily on cytotoxic CD8+ T lymphocytes and binds to programmed cell death ligand 1 (PD-L1) expressed on tumor cells, while CTLA-4 is expressed on regulatory T cells and other activated T cells and binds to B7 expressed on antigen-presenting cells. This evidence concerns the gene CD8A and neoplasm.